A Double-blind, Placebo Controlled, Randomized, Cross-over, Phase IIa Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia in Healthy Subjects
Phase of Trial: Phase II
Latest Information Update: 18 May 2011
At a glance
- Drugs Bimosiamose (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 18 May 2010 Positive results reported in a Revotar Biopharmaceuticals media release.
- 06 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.